13F HOLDINGS REPORT
Catalio Capital Management, LP
Quarter ended Q3 2025 · Filed November 14, 2025 · Accession 0001958125-25-000009
Total Value
$540.9M
Positions
38
Other Managers
0
Confidential Omitted
No
Holdings (38)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ELI LILLY & CO | LLY | 57,376 | $43.8M | 8.09% |
| 2 | ABBVIE INC | ABBV | 154,834 | $35.9M | 6.63% |
| 3 | BRIDGEBIO PHARMA INC | BBIO | 622,729 | $32.3M | 5.98% |
| 4 | INTUITIVE SURGICAL INC | ISRG | 71,343 | $31.9M | 5.90% |
| 5 | ASCENDIS PHARMA A/S | ASND | 144,954 | $28.8M | 5.33% |
| 6 | SOLENO THERAPEUTICS INC | SLNO | 418,245 | $28.3M | 5.23% |
| 7 | DIANTHUS THERAPEUTICS INC | DNTH | 667,615 | $26.3M | 4.86% |
| 8 | BOSTON SCIENTIFIC CORP | BSX | 262,972 | $25.7M | 4.75% |
| 9 | SYNDAX PHARMACEUTICALS INC | SNDX | 1,614,717 | $24.8M | 4.59% |
| 10 | CYTOKINETICS INC | CYTK | 451,581 | $24.8M | 4.59% |
| 11 | NATERA INC | NTRA | 148,369 | $23.9M | 4.42% |
| 12 | REGENERON PHARMACEUTICALS | REGN | 35,344 | $19.9M | 3.67% |
| 13 | STRUCTURE THERAPEUTICS INC | GPCR | 651,810 | $18.3M | 3.37% |
| 14 | UNIQURE NV | QURE | 282,940 | $16.5M | 3.05% |
| 15 | DISC MEDICINE INC | IRON | 216,527 | $14.3M | 2.65% |
| 16 | ABIVAX SA | AAVXF | 162,141 | $13.8M | 2.54% |
| 17 | SUPERNUS PHARMACEUTICALS INC | SUPN | 287,090 | $13.7M | 2.54% |
| 18 | EXACT SCIENCES CORP | 30063P105 | 248,987 | $13.6M | 2.52% |
| 19 | PHATHOM PHARMACEUTICALS INC | PHAT | 1,128,521 | $13.3M | 2.46% |
| 20 | ADAPTIVE BIOTECHNOLOGIES COR | ADTI | 884,890 | $13.2M | 2.45% |
| 21 | AVIDITY BIOSCIENCES INC | 05370A108 | 263,256 | $11.5M | 2.12% |
| 22 | ADMA BIOLOGICS INC | ADMA | 684,508 | $10.0M | 1.86% |
| 23 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 291,262 | $8.8M | 1.62% |
| 24 | FRACTYL HEALTH INC | GUTS | 5,214,236 | $8.3M | 1.53% |
| 25 | GRAIL INC | GRAL | 137,928 | $8.2M | 1.51% |
| 26 | PROTARA THERAPEUTICS INC | TARA | 1,500,793 | $6.5M | 1.21% |
| 27 | SEPTERNA INC | SEPN | 294,360 | $5.5M | 1.02% |
| 28 | CIDARA THERAPEUTICS INC | 171757206 | 53,333 | $5.1M | 0.94% |
| 29 | KYVERNA THERAPEUTICS INC | KYTX | 586,909 | $3.5M | 0.65% |
| 30 | ELEDON PHARMACEUTICALS INC | ELDN | 1,061,132 | $2.7M | 0.51% |
| 31 | OUTSET MED INC | OM | 118,279 | $1.7M | 0.31% |
| 32 | METAGENOMI INC | MGX | 528,993 | $1.3M | 0.23% |
| 33 | ATAI LIFE SCIENCES NV | N0731H103 | 196,858 | $1.0M | 0.19% |
| 34 | HYPERFINE INC | HYPR | 684,541 | $992,584 | 0.18% |
| 35 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 133,131 | $954,549 | 0.18% |
| 36 | KARYOPHARM THERAPEUTICS INC | KPTI | 142,984 | $935,115 | 0.17% |
| 37 | PALVELLA THERAPEUTICS INC NE | PVLA | 12,010 | $752,907 | 0.14% |
| 38 | SENSEI BIOTHERAPEUTICS INC | SNSE | 14,718 | $139,085 | 0.03% |